International. The addition of Polyzen, a developer of polymer-based coating and film technologies, will expand the company's design and manufacturing capabilities in advanced biomaterials and expand the service it offers its customers.
Solesis announces that it has acquired Polyzen, a developer and manufacturer of polymer-based coating and film technologies for the biopharmaceutical and medical device industries.
The addition of Polyzen will expand Solesis' design and manufacturing capabilities in advanced biomaterials and expand the service it offers to its customers.
"We are excited about what this new partnership will mean for our customers in the future," said Solesis CEO Karen West.
"Polyzen enhances Solesis' range of polymer-based technologies, expertise and capabilities, all of which will enable us to continue to provide innovative solutions to our customers," said West.
Polyzen co-CEOs Nikin and Rubin Shah commented, "We are excited to combine our decades of experience in polymer science in film and coating technologies with Solesis' market leadership in advanced biomaterials."
"As part of Solesis, we look forward to innovating and developing polymer technology solutions to support our global bioprocessing and medical device customers."
Headquartered in Apex, North Carolina, Polyzen will operate as a subsidiary of Solesis.
